
The Safety Nucleus: From Compliance to Strategic Enabler
Ipsen’s Pav Rishiraj joins David Kološić to discuss why pharmacovigilance is the nucleus of the industry, and how moving from reactive to predictive safety will improve benefit-risk analysis and establish safety as a str
Show notes
![Safety [R]Evolution](https://pbcdn1.podbean.com/imglogo/image-logo/21151572/Safety_R_evolution_Podbean_Tile_2048x20487sh18.png)













